Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSA Response-based Salvage Radiotherapy for Prostate Cancer
NCT07313241Phase 2Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2025
- Primary completion
- Nov 2030
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by UT Southwestern Medical Center. Primary endpoint: Freedom from failure at 2 years. Started Nov 2025; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07313241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07313241.